Shortage of drugs in Russia is deepening

The shortage of drugs in Russia is deepening, and is currently being observed in almost 70 regions throughout the country and forcing the local state to consider ways to resume stable supplies to local market, reports The Pharma Letter’s local correspondent.

Probably the biggest problems are currently seen in case of drugs against cancer and diabetes, stocks of which in Russian pharmacies have significantly declined in recent months. At the same time the situation in state segment of the market is better.

In the case of anti-cancer treatments, so far, Russia has faced a shortage of a number of drugs, which contain such active ingredients as ribociclib, enzalutamide, olaparib, lorlatinib, entrectinib, cabozantinib and some others.